1. Optovue

    0 Comments Leave a Comment

    1-15 of 777 1 2 3 4 ... 50 51 52 »
    1. Mentioned In 777 Articles

    2. Quantitative evaluation of retinal microvascular circulation in patients with obstructive sleep apnea–hypopnea using optical coherence tomography angiography

      Quantitative evaluation of retinal microvascular circulation in patients with obstructive sleep apnea–hypopnea using optical coherence tomography angiography
      .... The clinical characteristics were collected, OCT and OCTA scans using OCTA RT XR Avanti (AngioVue software, Optovue Inc., Fremont, CA, USA) were performed and analyzed. Results Compared to the control group, the severe...
      Read Full Article
    3. Correlation of retinal sensitivity in microperimetry with vascular density in optical coherence tomography angiography in primary open-angle glaucoma

      Correlation of retinal sensitivity in microperimetry with vascular density in optical coherence tomography angiography in primary open-angle glaucoma
      ...m the fovea and covered a circular macula area of 6mm in diameter. The study used the Avanti Angiovue system (Optovue, Inc. Fremont, CA, USA), which provides non-invasive visualization of the retinal vascular network thr...
      Read Full Article
    4. Macular and Peripapillary OCTA Metrics Predict Progression in Diabetic Retinopathy: A Sub-analysis of TIME-2b Study Data

      Macular and Peripapillary OCTA Metrics Predict Progression in Diabetic Retinopathy: A Sub-analysis of TIME-2b Study Data
      ...bjects included in the study 39 (53.4%) were imaged on the Zeiss Cirrus device, 23 (31.5%) were imaged on the Optovue Avanti device, and 12(15.1%) were imaged on the Topcon Triton device. Table 2 summarizes baseline char...
      Read Full Article
    5. Discordant vascular parameter measurements in diabetic and non-diabetic eyes detected by different optical coherence tomography angiography devices

      Discordant vascular parameter measurements in diabetic and non-diabetic eyes detected by different optical coherence tomography angiography devices
      ... al reported that the average area value of the FAZ was significantly different between all instrument pairs (Optovue, Canon and Heidelberg).[21] In addition, Corvi et al found that VD and FAZ measurements were different...
      Read Full Article
    6. 1-15 of 777 1 2 3 4 ... 50 51 52 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. About Optovue

    Optovue

    Optovue, Inc., a privately-held medical device company founded in 2003 and based in Fremont, Calif., is dedicated to the development and commercialization of high-speed optical coherence technology used to facilitate the diagnosis and management of eye diseases, many of which may lead to permanent blindness. For more information, visit www.optovue.com.

  3. Quotes about Optovue

    1. Our customers around the world provided a 19% revenue increase for 2009 over 2008...We have continuing strong support by representatives and distributor's world-wide, and all regions including the US are up significantly from 2008. The first fiscal quarter of 2010 demonstrated still another significant increase over 2009 numbers. The trend is clearly demonstrating that the clinical package offered by Optovue products is still highly desirable when faced with a number of product options.
      Gordon Wong in Optovue Announces 19% 2009 Revenue Increase Over 2008
    2. Gaining market share in the home country where Optovue manufactures is always satisfying...“Gaining market share in the home country where Optovue manufactures is always satisfying...The mission in 2012 is to continue our market growth world-wide utilizing our new TCP (Total Cornea Power) and V TRAC (Eye Tracking) options; as well as expand our iWellness programs.
      In Optovue Announces US sales orders for advanced OCT up 32% over previous year
    3. Haag-Streit is happy to partner with Optovue for its leadership in OCT technology and outstanding customer service. Our bundled technologies will create an advanced package that will provide a superior diagnostic tool to the ophthalmic industry.
      In Haag-Streit USA and Optovue Team Up to Introduce Octopus/Optovue Bundle